Research at Hadassah Shows Promising Results for Patients With Progressive MS

March 29, 2024

Research at Hadassah Shows Promising Results for Patients With Progressive MS

In a study presented in March at the 2024 Forum of the Americas Committee for Treatment and Research in Multiple Sclerosis, Dr. Petrou Panayiota, a neurologist at Hadassah Hospital Ein Kerem, presented evidence of significant beneficial effects of repeated stem cell injections in patients with progressive multiple sclerosis.

Researchers in the study, co-authored by Prof. Dimitrios Karussis, head of Hadassah’s Multiple Sclerosis Center, noted improvements not only in neurological function, but also in cognition and quality of life. Moreover, there were no adverse effects on the 23 participants in the study.

As Dr. Panayiota explained, “Importantly, with this treatment, we see not just benefit but improvement. We do not usually see that in progressive patients.”

For more details on the multiple sclerosis research being conducted by Dr. Panayiota and her colleagues at Hadassah, read the full story in Practice Update.

Read More

[Hadassah On Call] World-Renowned Multiple Sclerosis Expert Reveals Groundbreaking Research
Video: Professor Dimitrios Karussis on Treating MS
Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS
"Stunning Results" Continue with Hadassah's Stem Cell Treatment to Reverse MS

No items found.